IRIDEX - Stock

IRIDEX Revenue 2024

IRIDEX Revenue

51.41 M USD

Ticker

IRIX

ISIN

US4626841013

WKN

912341

In 2024, IRIDEX's sales reached 51.41 M USD, a -0.89% difference from the 51.87 M USD sales recorded in the previous year.

The IRIDEX Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e70.2131,06
2025e53.3540,88
2024e51.4142,42
202351.8742,04
202256.9744,53
202153.942,36
202036.3542,81
201943.4541,29
201842.641,01
201741.5937,27
201646.1645,15
201541.7647,77
201442.8150,01
201338.2748,58
201233.8648,29
201133.1649,13
201032.3150,14
200931.0349,76
200848.5340,55
200755.5343,72
200635.952,40
200537.0349,10
200432.8145,38

IRIDEX Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into IRIDEX, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by IRIDEX from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects IRIDEX’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of IRIDEX. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into IRIDEX’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing IRIDEX’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on IRIDEX’s growth potential.

IRIDEX Revenue, EBIT and net profit per share

DateIRIDEX RevenueIRIDEX EBITIRIDEX Net Income
2026e70.21 M undefined-5.27 M undefined-5.85 M undefined
2025e53.35 M undefined-5 M undefined-4.48 M undefined
2024e51.41 M undefined-7.55 M undefined-8.12 M undefined
202351.87 M undefined-10.01 M undefined-9.57 M undefined
202256.97 M undefined-7.54 M undefined-7.55 M undefined
202153.9 M undefined-7.53 M undefined-5.23 M undefined
202036.35 M undefined-6.58 M undefined-6.33 M undefined
201943.45 M undefined-8.97 M undefined-8.81 M undefined
201842.6 M undefined-12.87 M undefined-12.81 M undefined
201741.59 M undefined-13.03 M undefined-12.87 M undefined
201646.16 M undefined-2.45 M undefined-11.71 M undefined
201541.76 M undefined290,000 undefined470,000 undefined
201442.81 M undefined2.59 M undefined10.04 M undefined
201338.27 M undefined2.16 M undefined2.23 M undefined
201233.86 M undefined-860,000 undefined1.44 M undefined
201133.16 M undefined660,000 undefined2.61 M undefined
201032.31 M undefined1.19 M undefined3.05 M undefined
200931.03 M undefined1.23 M undefined2.59 M undefined
200848.53 M undefined-2.18 M undefined-7.37 M undefined
200755.53 M undefined-9.43 M undefined-22.27 M undefined
200635.9 M undefined-4.77 M undefined-5.75 M undefined
200537.03 M undefined1.81 M undefined1.67 M undefined
200432.81 M undefined-1.08 M undefined-400,000 undefined

IRIDEX stock margins

The IRIDEX margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IRIDEX. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IRIDEX.
  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the IRIDEX's sales revenue. A higher gross margin percentage indicates that the IRIDEX retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the IRIDEX's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the IRIDEX's total revenue generated. When comparing the revenue margin year over year, investors can gauge the IRIDEX's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the IRIDEX. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the IRIDEX's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

IRIDEX Margin History

IRIDEX Gross marginIRIDEX Profit marginIRIDEX EBIT marginIRIDEX Profit margin
2026e42.04 %-7.51 %-8.33 %
2025e42.04 %-9.37 %-8.39 %
2024e42.04 %-14.68 %-15.8 %
202342.04 %-19.29 %-18.45 %
202244.53 %-13.24 %-13.25 %
202142.36 %-13.97 %-9.7 %
202042.81 %-18.1 %-17.41 %
201941.29 %-20.64 %-20.28 %
201841.01 %-30.21 %-30.07 %
201737.27 %-31.33 %-30.94 %
201645.15 %-5.31 %-25.37 %
201547.77 %0.69 %1.13 %
201450.01 %6.05 %23.45 %
201348.58 %5.64 %5.83 %
201248.29 %-2.54 %4.25 %
201149.13 %1.99 %7.87 %
201050.14 %3.68 %9.44 %
200949.76 %3.96 %8.35 %
200840.55 %-4.49 %-15.19 %
200743.72 %-16.98 %-40.1 %
200652.4 %-13.29 %-16.02 %
200549.1 %4.89 %4.51 %
200445.38 %-3.29 %-1.22 %

IRIDEX Aktienanalyse

What does IRIDEX do?

IRIDEX Corp is a global medical technology company that specializes in the development, manufacturing, marketing, and distribution of innovative laser-based medical devices and services. The company was originally founded in 1989 and is headquartered in Mountain View, California. IRIDEX's business model is divided into various divisions, each serving different markets. The divisions include ophthalmology, otolaryngology (ENT), gynecology and urology, as well as scientific research. The company offers a wide range of high-tech laser systems that can be used to treat various conditions, such as retinal diseases, glaucoma, nasal and throat disorders, gynecological and urological conditions, and other medical applications. One of the most well-known divisions of IRIDEX is ophthalmology, which offers a wide range of laser systems for the treatment of retinal diseases. These retinal diseases include diabetic retinopathy, retinal edema, age-related macular degeneration, and retinal detachment. The company also has a high-tech system called Cyclo G6TM, which is used for the treatment of glaucoma. This system can also be used in conjunction with other devices, such as ultrasound systems, for optimized clinical effectiveness. The ENT division offers laser systems for the treatment of nasal and throat disorders, such as snoring, polyps, stenosis, and tumors. The range of laser systems varies from simple systems to advanced systems that can be connected to a flexible endoscope for more precise treatment. IRIDEX's gynecology and urology division offers laser systems for various applications, such as urinary incontinence, bladder problems, tumor removal, prostate tissue removal, and medical treatments to improve sexual function. Laser systems can also be used in combination with other medical devices, such as ultrasound systems. The company places great emphasis on scientific research and development to create and introduce innovative technologies to the market. Therefore, IRIDEX collaborates closely with various research institutes, universities, and medical professionals to further develop its technological advances. The company is also committed to providing comprehensive training and support to its customers to ensure that they use the devices safely and effectively. Overall, IRIDEX Corp has established itself as an innovative and powerful multinational company in the field of medical technology. The company is constantly striving to expand its range of products and services and impress its customers with its high-quality solutions. IRIDEX is confident that it will continue to play a significant role in the medical technology industry in the future. IRIDEX ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding IRIDEX's Sales Figures

The sales figures of IRIDEX originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing IRIDEX’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize IRIDEX's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in IRIDEX’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about IRIDEX stock

How much revenue did IRIDEX generate this year?

IRIDEX has achieved a revenue of 51.41 M USD this year.

How much was the turnover of the company IRIDEX compared to the previous year?

The revenue of IRIDEX has increased by -0.89% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of IRIDEX?

The revenue of IRIDEX is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of IRIDEX measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of IRIDEX so important for investors?

The revenue of IRIDEX is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does IRIDEX pay?

Over the past 12 months, IRIDEX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IRIDEX is expected to pay a dividend of 0 USD.

What is the dividend yield of IRIDEX?

The current dividend yield of IRIDEX is .

When does IRIDEX pay dividends?

IRIDEX pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IRIDEX?

IRIDEX paid dividends every year for the past 0 years.

What is the dividend of IRIDEX?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IRIDEX located?

IRIDEX is assigned to the 'Health' sector.

Wann musste ich die Aktien von IRIDEX kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IRIDEX from 7/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/8/2024.

When did IRIDEX pay the last dividend?

The last dividend was paid out on 7/8/2024.

What was the dividend of IRIDEX in the year 2023?

In the year 2023, IRIDEX distributed 0 USD as dividends.

In which currency does IRIDEX pay out the dividend?

The dividends of IRIDEX are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IRIDEX

Our stock analysis for IRIDEX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IRIDEX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.